A research group led by The University of Osaka has developed a novel method for analyzing cancer metabolism, revealing new ...

“Most folks who are diagnosed with them end up dying from them, usually within a year or two. We don't have great treatments.

Researchers at Purdue University are exploring how a molecular mechanism that acts as a natural break on cancer functions. Their work opens the door to developing drugs that capitalize on the ...

UCSF researchers designed a CAR T-cell therapy and combined it with an older class of diabetes drugs called ...

Ahead of Prostate Cancer Awareness Month, the most common cancer among men, here is everything about the new treatment already in use in Israel that brings hope to patients.

In 2000, researchers discovered that mutations that inactivate a gene known as TRIM37 cause a developmental disease called ...

Dr. Geoffrey Liu discussed findings from the phase 2 TRUST-II clinical trial evaluating Ibtrozi (taletrectinib) among ...

Urothelial carcinoma (UC) is the second most common genitourinary cancer, leading to over 16,000 deaths a year in the U.S. Despite recent advances, the five-year survival rate for metastatic UC ...

Researchers at NYU Langone Health discovered that cutting off blood flow accelerates cancer growth by prematurely aging the ...